Sun Pharma shares rose sharply on Sunday after the company reported a 16% YoY rise in Q3 net profit to Rs 3,369 crore, supported by strong India business and improved margins. The firm also declared an interim dividend of Rs 11 per share, further boosting sentiment despite cautious institutional activity.
Related Posts
Oil hovers near multi-month highs as Trump considers Iran strike
- nationalpillarnews
- January 30, 2026
- 0
U.S. President Donald Trump urged Iran on January 28, 2026 to come to the table and make a deal on nuclear weapons or face a […]
WHO chief says reasons U.S. gave for withdrawing ‘untrue’
- nationalpillarnews
- January 25, 2026
- 0
Tedros Adhanom Ghebreyesus warned that U.S. announcement this week that it had formally withdrawn from the WHO “makes both the U.S. and the world less […]
WPL 2026: Mumbai Indians Face Gujarat Giants In Crucial Clash For Playoff Spots
- nationalpillarnews
- January 30, 2026
- 0
Gujarat Giants face Mumbai Indians in a crucial clash tonight. With RCB already in the final, both teams are fighting for the last two playoff […]